Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2017

GlobalData
76 Pages - GLDATA62070
$2,500.00

Summary

GlobalData's clinical trial report, “Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2017" provides an overview of Adrenocortical Carcinoma (Adrenal Cortex Cancer) clinical trials scenario. This report provides top line data relating to the clinical trials on Adrenocortical Carcinoma (Adrenal Cortex Cancer). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies Mentioned

Pfizer Inc
Novartis AG
Astellas Pharma Inc
Merck & Co Inc
Eli Lilly and Company
E. Merck KG
AstraZeneca Plc
ArQule Inc
Arbutus Biopharma Corp
AbbVie Inc

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Adrenocortical Carcinoma (Adrenal Cortex Cancer) to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Adrenocortical Carcinoma (Adrenal Cortex Cancer) to Oncology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profile Snapshots 28
Appendix 73
Abbreviations 73
Definitions 73
Research Methodology 74
Secondary Research 74
About GlobalData 75
Contact Us 75
Disclaimer 75
Source 76

List of Tables
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Region, 2017* 6
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
Proportion of Adrenocortical Carcinoma (Adrenal Cortex Cancer) to Oncology Clinical Trials, G7 Countries (%), 2017* 14
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Adrenocortical Carcinoma (Adrenal Cortex Cancer) to Oncology Clinical Trials, E7 Countries (%), 2017* 17
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Phase, 2017* 19
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 20
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 24
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27

List of Figures
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Proportion of Adrenocortical Carcinoma (Adrenal Cortex Cancer) to Oncology Clinical Trials, G7 Countries (%), 2017* 14
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Adrenocortical Carcinoma (Adrenal Cortex Cancer) to Oncology Clinical Trials, E7 Countries (%), 2017* 17
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 19
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 20
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 24
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27
GlobalData Methodology 74

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports